CAMBRIDGE, Mass. - Nuvalent, Inc. (NASDAQ:NUVL), a clinical-stage biopharmaceutical company, has announced the publication of a manuscript in Cancer Discovery (NASDAQ:WBD) journal, presenting the ...
CAMBRIDGE, Mass., Oct. 4, 2023 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈